Thymic tumours are so relatively rare that even centres that have a special interest in them will probably treat no more than a few each year. In contrast, the complications that are associated with their radiotherapy are so commonplace that the radiotherapist has to be alert for possible hazards from the start of treatment.
When planning the treatment for a thymic tumour it is necessary to cover not only the whole volume of the tumour as demonstrated by the various radiographic investigations, but also the known anatomical extent of the normal thymic gland. The level of the 6th cervical vertebra is taken as the upper limit of the cervical extension of the two lobes. The thoracic portion of the gland lies in the anterior part of the superior mediastinum, extending down to the level of the 4th costal cartilage. Although most thymic tumours are found in the anterior mediastinum, occasionally one comes upon a case where the tumour extends down as far as the diaphragm. Thus it can be seen that however small the tumour may appear to be, one has no alternative but to treat a moderately large volume. In practice it is usual to have to treat a tumour volume 15 cm long. The field arrangement will be influenced not only by the distribution of the tumour but also by the size and shape of the patient. A single anterior and two postero-oblique fields give a satisfactory dose distribution in most cases, which is best achieved by a linear accelerator.
Histologically thymic tumours are of a very variable appearance, showing the characteristic presence of lymphatic tissue to a greater or lesser extent. As lymphatic tissue exhibits a high degree of radiosensitivity the manner of response of thymic tumours will be determined by the proportionate presence of this tissue in the tumour structure. There have been many cases of thymic tumour which have been reported as responding to doses as low as 1500 rads. This is not surprising if the lymphatic element in the tumour is in preponderance, but such a low dosage is unlikely to affect -the epithelial cells in a thymic tumour. Doses in the region of 5000-6000 rads are necessary to sterilize these cells, but the mediastinum will not tolerate such high doses. In practice one strikes a compromise, giving a dose of around 4000 rads in 4-5 weeks, and even at this dose level complications are all too frequent. Case 1 This patient presented with a very short history of myasthenia gravis and rapidly deteriorated as soon as radiotherapy was commenced. X-rays ofhis mediastinum revealed a large tumour involving the right lobe of the thymus. Clinically there were well-established stigmata of bulbar myasthenia which made it all the more necessary to admit the patient for several days before attempting to embark upon treatment. This enabled his exact requirements of neostigmine to be stabilized, and a normal baseline for his temperature and pulse record to be discovered. The daily treatment took place after a dose of neostigmine so that his muscular power was at its optimum. On the first day a tumour dose of under 100 rads was given to prevent aggravating the myasthenic symptoms. Despite all these precautions, within eight days of starting treatment there was a marked deterioration in the patient's myasthenic state, so much so that both neostigmine and Mestinon had to be administered virtually every hour during the day. His requirements for these drugs varied so much that the regime had to be reviewed each day and when at times he was unable to swallow, injections had to be substituted for the tablets. Even with such careful supervision, it is all too easy to reach a situation where it is by no means clear whether the patient is in fact receiving sufficient neostigmine or possibly too muchthe symptoms are the same. Only an injection of Tensilon will make clear whether the myasthenic symptoms are due to an excess or to a deficiency of neostigmine.
At last, -twelve weeks later this patient's treatment was completed and X-rays confirmed that there had been good regression of the tumour mass. Subsequently, thymectomy was carried out and he developed osteomyelitis of the sternum. This is an uncommon complication but it is well known that irradiation may cause devitilization of bone, making it more susceptible to infection.
However, 41 years after treatment he remains well.
Whenever the chest is irradiated there is a possibility of stimulating possible latent pulmonary infection. Some radiotherapists feel that it is essential to give a covering umbrella of antibiotics during a course of radiotherapy for all patients who have any signs of bronchitis. Furthermore, patients with myasthenia gravis characteristically have an increased liability to chest infections and so special attention must be given to this aspect of the management. This is not only because of the seriousness of acute pulmonary infection in such patients but also because it is a predisposing factor to the development of pulmonary fibrosis following an episode ofradiation pneumonitis. Case 2 A mediastinal shadow was found in this patient in 1960 following a routine chest X-ray. It remained unchanged for three years but then started steadily to enlarge. He remained sympton free until 1968, when he started to develop troublesome pains radiating down both his arms.
A thymic venogram (Dr L Kreel) showed conclusively that the mass was in fact arising from the thymus and was compressing the right thymic vein. Shortly afterwards the patient was established on a course of radiotherapy. All went well for the first three weeks, so much so that he was allowed to go home for a weekend. When he returned he was unwell with symptoms of influenza, of which there was an epidemic at that time. Three days later he developed lobar pneumonia which was treated with intense antibiotic therapy. In spite of this the pyrexia persisted for three days, by which time signs of cardiac failure were developing. Intensive treatment failed and the patient died shortly afterwards in renal failure.
A post-mortem examination was refused. One can only speculate on possible precipitating pathological features, but since there was no previous cardiac history and heart failure developed so rapidly, it is possible that there was some infiltration of the heart by tumour. Thymic tumours in contiguity with the heart seldom produce a pericardial effusion or symptoms, but they are known to infiltrate the pericardium and even the myocardium. Radiation carditis has received considerable attention from several workers including Jones (1960), who concluded that cardiac complications are virtually unknown, even after doses in excess of 5000 rads given in the treatment of an cesophageal tumour. Nevertheless, radiation carditis is recognized as a hazard in any condition in which the pericardium is invaded by tumour. In Jones's series, 7% of all the thymic tumours treated developed pericarditis. Case 3 This patient was originally investigated for symptoms that included cough, dysphagia and increasing tiredness. Routine chest X-ray showed a large mediastinal shadow, which was subsequently confirmed by a thymic venogram (Dr L Kreel), to be arising in the thymus. On account of the large size and irregular delineation of the tumour mass, it was impossible to treat the region by the recommended three-field technique, the aim of which is to concentrate the treatment into as small a volume as possible. Therefore, it was decided to treat the patient initially by a simple technique of parallel opposed fields, changing to the three-field technique as soon as there was sufficient reduction in the size of the tumour mass to make this possible. Within ten days of starting treatment, the patient became very ill with signs of pericarditis and heart failure. The course of radiotherapy was immediately suspended and the patient was given intensive treatment including the use of high doses of prednisolone. His condition gradually improved but two complicating features were noticed: first, an effusion at the left base and to a lesser extent on the right, and, secondly, the liver was enlarged; 800 ml of fluid was aspirated from the effusion and since there were several unusual features about the case, not the least of which was the failure of the tumour mass to respond to radiotherapy, a liver biopsy was performed. No useful information was gained either from this or from examination of the fluid aspirated from the chest. Therefore, as soon as it was thought to be safe, the course of radiotherapy was resumed and in fact was completed without further interruption. The patient was seen at regular intervals but the long-awaited response of the tumour mass did not materialize. Two months after completion of treatment the patient suddenly became very ill and when admitted was found to have not only a liver enlarged down to the right iliac fossa, but also a skin nodule on the posterior abdominal wall. Within twenty-four hours he had died. Autopsy revealed a large tumour at the site of the thymus with the macroscopic appearances of a thymoma. It had not only invaded the pericardium but had also spread by direct extension into the medial aspect of the left lung. The liver was grossly enlarged by a diffuse tumour mass and deposits were also found in the thyroid, in both adrenals and in the lower part of the left pleural cavity. No thymic tissue was seen in the main tumour mass and there was no positive evidence apart from the site of the original tumour to suggest that this was a primary epithelial-type thymoma.
The problem of a patient with a known asymptomatic anterior mediastinal tumour is a recurrent one and makes one wonder whether more attention should be given to establishing a tissue diagnosis by means of mediastinoscopy. Case 4 This patient was referred in 1968 for consideration for radiotherapy as he had developed superior venacaval obstruction and also a painful mass over the anterior chest wall on the left. At this time the chest X-ray showed complete opacification of the left side of the thorax, with a marked shift of the trachea to the opposite side.
Nine years previously the patient had attended another hospital with exertional dyspncea and was noted to have several rounded shadows in the left chest, probably associated with the pleura.
Since then there had been a very gradual deterioration in his condition. This slow progress of the disease, together with the original chest X-ray findings, suggested a diagnosis of thymoma. In view of this he was started on a palliative course of cobalt teletherapy to alleviate the superior venacaval obstruction, at the same time covering the painful swelling on the anterior chest wall on the left. The area to be treated was so massive that no attempt was made to cover the lower third of the tumour volume. In five weeks, using a simple parallel opposed arrangement of fields, an effective tumour dose of 3600 rads was given. The response to treatment was dramatic and the patient himself remarked that not only was his breathing much easier, but also the venous engorgement in his neck and abdomen was much less. Shortly afterwards he returned to work and six months later the lower part of the tumour area which had not been covered by the original treatment was irradiated. It was inevitable that gross fibrosis would occur following treatment in view of the extent and long standing of the tumour. The patient remained well for eighteen months but developed influenza in 1970 which led to pneumonia within a day or two and, being without any pulmonary reserve in the opposite lung, he very soon died. This is an extreme case that emphasizes the importance of being aware of the dangers of chest infection developing in patients with pulmonary fibrosis following radiotherapy.
The complication most frequently mentioned when treatment of the mediastinum is being considered is mediastinitis. However, this is a complication that has hardly troubled any of my patients. It is usually a clear-cut condition heralded by a complaint of pains in the anterior chest. The patient looks exceedingly ill and the temperature chart will show an inordinate rise of the pulse rate in relationship to the temperature. This is a danger signal which must never be ignored; the radiotherapy must be suspended immediately and the patient established on high doses of steroids, together with a wide-spectrum antibiotic. Only when the signs and symptoms have completely resolved should one attempt cautiously to restart radiotherapy.
These few cases that I have reported give some idea of the problems that may be involved in irradiating thymic tumours and emphasize the need for the closest supervision throughout and even after treatment. The normal infant or small child has a visible thymic shadow on the chest radiograph. This merges with the heart shadow and may even be mistaken for cardiac enlargement on the frontal view but on the lateral view the increased shadow is seen to be anterior. In cardiac enlargement the increased shadowing extends towards or over the spine. The typical sail-shaped shadow occurs on the right side. It is well recognized that the thymus shrinks during chronic illness, malnutrition, after steroids and immunosuppressives and with radiotherapy. The thymus is then not visible (Caffey 1967) on the chest radiograph. On removal of the above factors the thymus will return to its normally visible state. However, steroids may on occasion fail to shrink the large infant thyroid (Felson 1972) but this does not denote any pathological state. Another condition in which the thymus is not visible is in immunological incompetence, particularly hypogammaglobulinmmia and Di George syndrome.
In the adult the enlarged thymus may become visible on the plain film of the chest. It usually assumes the typical 'thymic' shape, just as the kidney or spleen has a typical shape (Kreel 1970) . This is best seen when an effusion occurs into the thymic bed following thymectomy. When a thymoma is small its shadow can be accentuated by the oblique position as these tumours lie in the anterior mediastinum. On the left side they mimic enlargement of the main pulmonary artery. A thymoma may calcify, appearing as a curvilinear density, coarse trabeculation or amorphous shadow. A penetrated frontal view or a lateral film is required for its demonstration. Tomography is seldom if ever needed to show a thymic shadow which was not already visible on plain films or fluoroscopy. The spread of a malignant thymus is by direct extension in the mediastinum or onto the pleura producing typical pleural deposits. In the late stage there is diaphragmatic paralysis, pleural effusion and mediastinal shift. Uncommonly thymomas also produce metastases, especially to the liver.
Pneunwmediastinography
However, if thymomas are to be diagnosed when they are 1.5-2 cm in diameter pneumomediastinography is required. This is performed by the insertion of a needle through the manubriosternal joint so that its tip is just beyond the retrosternal fascia (Kreel & James 1965); 500-600 ml of air is injected very slowly, producing a feeling of tightness but no pain. The normal adult thymus shows parallel anterior and posterior walls except inferiorly where it becomes pointed. Its anteroposterior width varies from 0.5 to 2.5 cm, corresponding respectively to roughly 8 and 25 g in weight. A tumour is shown by a curvilinear contour. This is most easily seen on the lateral view. When demonstrated on the frontal view it can be accurately localized ( Fig IA) .
Thymic Venography
The thymus can also be demonstrated by selective retrograde venography (Kreel 1967) performed either from the left arm (Fig 1B) or the right femoral vein. With the tip of the catheter lodged in the central thymic vein (of Keynes) an injection
